Designed by China's ministry of public security, the "national anti-fraud center" became the second most downloaded iOS app globally in September
Investors are rattled by the FDA's request for an out-of-the-ordinary meeting dedicated to scrutinizing the company's latest drug approval request.
A recent letter sent by Donald Trump seems to have renewed some hope in Fannie and Freddie shareholders.
Shares of Vir Biotechnology (NASDAQ: VIR) were soaring 18.5% as of 11:08 a.m. ET on Tuesday. The big gain came after H.C. Wainwright analyst Patrick Trucchio boosted his price target on Vir from $135 to $200. Several analysts are bullish about Vir's prospects.
AT&T Inc. shares are leading a wireless selloff Tuesday after the company gave a presentation at an investor conference that one analyst said "reinforced market fears" about what its customer-acquisition spending could mean for broader industry trends.
On Nov. 15, institutional investors and hedge funds with at least $100 million in assets under management were required to file Form 13F with the Securities and Exchange Commission (SEC). With the latest round of 13Fs, one thing stands out: billionaires were buying stocks hand over fist. Billionaire Ken Griffin is a wildly successful investor who's known for extracting big wins from his firms' options positions.
Shares of semiconductors star Nvidia (NASDAQ: NVDA) declined 4.4% through 12:12 p.m. ET Tuesday. Specifically, Fed Chairman Jerome Powell just told a Senate panel that the Fed is considering accelerating winding down its bond-buying program and concluding its tapering "a few months sooner" than previously expected. The Nasdaq has nearly tripled in price over the past five years, and analysts attribute a lot of this growth to the fact that the Fed has been pumping as much as $120 billion a month in liquidity into the economy through its bond purchases.
Shares of cruise-line stocks are down again on Tuesday, with Carnival Corporation (NYSE: CCL) sliding 4.6% in 11 a.m. ET trading, and rivals Royal Caribbean (NYSE: RCL) and Norwegian Cruise Line Holdings (NYSE: NCLH) not far behind. As MarketWatch reports today, Moderna CEO Stéphane Bancel is warning that his company's Covid-19 vaccine may suffer "a material drop" in effectiveness at protecting patients from the new omicron variant of the SARS-CoV-2 coronavirus.
Shares of Apple (NASDAQ: AAPL) stock closed up 2.2% on Monday following a holiday weekend that featured new commentary on the company and its products from Bloomberg. Last week, if you recall, Apple shares got a boost from reports that the company is planning to build an electric car with autonomous driving capability and also has an augmented reality headset in the works -- one that will be powerful enough to work as a stand-alone device. Well, over the weekend, Bloomberg expanded on these reports, adding that Apple is also working to develop augmented reality (AR) glasses (i.e., something different from the headset) and predicting that consumers (and investors) might get their first look at the AR headset as early as June 2022 if the company decides to unveil it at Apple's planned Worldwide Developers Conference next June.
Wall Street has known its share of legends, but few of them have made as big a splash as “the Man Who Broke the Bank of England.” That nickname belongs to George Soros who earned the tag after famously betting against the British Pound in 1992; following the Black Wednesday crash, the hedge fund manager pocketed $1 billion in a single day. This is the stuff that Wall Street legends are made of. By then Soros was already incredibly successful and in the midst of steering his Quantum Fund to decad
Yahoo Finance Live's Julie Hyman breaks down some of the leading national headlines including Microsoft CED Satya Nadella selling half his stake in the company, Amazon allowing a new unionization vote in Alabama, and Lululemon firing back at Peloton with patent infringement lawsuit.
The Malvern firm has a deal that will get it 45% of sales of the Covid-19 vaccine in the United States, if the product gets FDA approval.
Don't forget about Novavax (NASDAQ: NVAX). Here's why Novavax stock could skyrocket in December. In this case, there could be increased demand for vaccines that are effective against the omicron variant.
Here are some of the top airline stocks to put on your watchlist as the sector gets hammered due to fresh COVID-19 fears.
It was a hot investment during the early stages of the pandemic, but that isn't the case anymore.
Fed Chair Powell, joined by Treasury Secretary Yellen, delivers his opening statement to the Senate Banking Committee, which touched on COVID, inflation, the labor market, and GDP growth.
You only have a couple more days to profit in two different ways from tax-loss selling. From a statistical point of view, that means you’re finding a security whose gyrations can explain or predict at least half of the movements of your tax loss sale candidate.
Ideally, your overall portfolio should beat the market average. But even the best stock picker will only win with some...
The professor is known for being bullish on stocks, yet even he says trouble’s coming.
CEO Satya Nadella sold about half his stake in the software company, according to recent filings with the Securities and Exchange Commission.
And the winner for the most used new term goes to… Omicron, of course. The new Covid-19 variant has added a whole new layer of uncertainty to, well, everything. Ok, not everything. Coronavirus stocks, unsurprisingly, swung higher. Amongst them, the ultimate 2020 coronavirus stock: Novavax (NVAX). The share gains continued the vaccine maker’s recent strong run, which has been based on its Covid-19 vaccine NVX-CoV2373 finally gaining traction with regulators in various regions. Plus, the company h